Impact of Increasing Margin Around the Lumpectomy Cavity to Define the Planning Target Volume for 3D Conformal External Beam Accelerated Partial Breast Irradiation

Medical Dosimetry

Volumn 32, Issue 4, 2007, Pages 254-262

  Cox, Brett W ^a   Horst, Kathleen C ^a   Thornton, Sherri ^a   Dirbas, Frederick M ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

3D conformal external beam radiotherapy (3DCRT); Accelerated partial breast irradiation (APBI); Breast cancer; Breast conserving therapy; Margin

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; PARTIAL MASTECTOMY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SIMULATION; TARGET ORGAN; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL;

EID: 35548969407     PISSN: 09583947     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meddos.2007.02.003     Document Type: Article

References (35)

1. Clark R.M., Whelan T., Levine M., et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: An update. Ontario Clinical Oncology Group. J. Natl. Cancer Inst. 88 (1996) 1659-1664
2. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. [see comment]. N. Engl. J. Med. 347 (2002) 1233-1241
3. Fisher B., Bryant J., Dignam J.J., et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. [see comment]. J Clin. Oncol. 20 (2002) 4141-4149
4. Forrest A.P., Stewart H.J., Everington D., et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. [see comment]. Lancet 348 (1996) 708-713
5. Fyles A.W., McCready D.R., Manchul L.A., et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. [see comment]. N. Engl. J. Med. 351 (2004) 963-970
6. Hughes K.S., Schnaper L.A., Berry D., et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. [see comment]. N. Engl. J. Med. 351 (2004) 971-977
7. Liljegren G., Holmberg L., Bergh J., et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. [see comment]. J. Clin. Oncol. 17 (1999) 2326-2333
8. Malmstrom P., Holmberg L., Anderson H., et al. Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: A randomised clinical trial in a population with access to public mammography screening. Eur. J. Cancer. 39 (2003) 1690-1697
9. Veronesi U., Marubini E., Mariani L., et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial. Ann. Oncol. 12 (2001) 997-1003
10. Rosen P.P., Fracchia A.A., Urban J.A., et al. "Residual" mammary carcinoma following simulated partial mastectomy. Cancer 35 (1975) 739-747
11. Fisher B., and Anderson S. Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. National Surgical Adjuvant Breast and Bowel Project. World J. Surg. 18 (1994) 63-69
12. Uppsala-Orebro Breast Cancer Study Group. Sector resection with or without postoperative radiotherapy for stage I breast cancer. A randomized trial. J. Natl. Cancer Inst. 82 (1990) 277-282
13. Clark R.M., McCulloch P.B., Levine M.N., et al. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J. Natl. Cancer Inst. 84 (1992) 683-689
14. Baglan K.L., Martinez A.A., Frazier R.C., et al. The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy. Int. J. Radiat. Oncol. Biol. Phys. 50 (2001) 1003-1011
15. King T.A., Bolton J.S., Kuske R.R., et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am. J. Surg. 180 (2000) 299-304
16. Lawenda B.D., Taghian A.G., Kachnic L.A., et al. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. Int. J. Radiat. Oncol. Biol. Phys. 56 (2003) 671-680
17. Polgar C., Major T., Somogyi A., et al. [Brachytherapy of the tumor bed after breast conserving surgery: New radiotherapeutic option in the management of early breast cancer]. Orvosi. Hetilap. 140 (1999) 1461-1466
18. Arthur D.W., Koo D., Zwicker R.D., et al. Partial breast brachytherapy after lumpectomy: Low-dose-rate and high-dose-rate experience. Int. J. Radiat. Oncol. Biol. Phys. 56 (2003) 681-689
19. Chen P.Y., Vicini F.A., Benitez P., et al. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: A method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma. Cancer 106 (2006) 991-999
20. Vicini F.A., Beitsch P.D., Quiet C.A., et al. First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: Results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial. Cancer 104 (2005) 1138-1148
21. Keisch M., Vicini F., Kuske R.R., et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. [see comment]. Int. J. Radiat. Oncol. Biol. Phys. 55 (2003) 289-293
22. Vaidya J.S., Baum M., Tobias J.S., et al. Targeted intra-operative radiotherapy (Targit): An innovative method of treatment for early breast cancer. Ann. Oncol. 12 (2001) 1075-1080
23. Veronesi U., Gatti G., Luini A., et al. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery. Arch. Surg. 138 (2003) 1253-1256
24. Formenti S.C., Truong M.T., Goldberg J.D., et al. Prone accelerated partial breast irradiation after breast-conserving surgery: Preliminary clinical results and dose-volume histogram analysis. Int. J. Radiat. Oncol. Biol. Phys. 60 (2004) 493-504
25. Vicini F., Winter K., Straube W., et al. A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: Initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319. Int. J. Radiat. Oncol. Biol. Phys. 63 (2005) 1531-1537
26. Vicini F.A., Remouchamps V., Wallace M., et al. Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. [see comment]. Int. J. Radiat. Oncol. Biol. Phys. 57 (2003) 1247-1253
27. Taghian A.G., Kozak K.R., Doppke K.P., et al. Initial dosimetric experience using simple three-dimensional conformal external-beam accelerated partial-breast irradiation. Int. J. Radiat. Oncol. Biol. Phys. 64 (2006) 1092-1099
28. Vicini F.A., Kestin L.L., and Goldstein N.S. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: A pathologic analysis. Int. J. Radiat. Oncol. Biol. Phys. 60 (2004) 722-730
29. Baglan K.L., Sharpe M.B., Jaffray D., et al. Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int. J. Radiat. Oncol. Biol. Phys. 55 (2003) 302-311
30. NSABP Protocol B-39/RTOG Protocol 0413. A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer. Available at: http://www.rtog.org/members/protocols/0413/0413.pdf. Accessed March 19, 2007.
31. Frazier R.C., Vicini F.A., Sharpe M.B., et al. Impact of breathing motion on whole breast radiotherapy: A dosimetric analysis using active breathing control. Int. J. Radiat. Oncol. Biol. Phys. 58 (2004) 1041-1047
32. Korreman S.S., Pedersen A.N., Nottrup T.J., et al. Breathing adapted radiotherapy for breast cancer: Comparison of free breathing gating with the breath-hold technique. Radiother. Oncol. 76 (2005) 311-318
33. Smith R.P., Bloch P., Harris E.E., et al. Analysis of interfraction and intrafraction variation during tangential breast irradiation with an electronic portal imaging device. Int. J. Radiat. Oncol. Biol. Phys. 62 (2005) 373-378
34. Vicini F., Baglan K., Kestin L., et al. The emerging role of brachytherapy in the management of patients with breast cancer. Semin. Radiat. Oncol. 12 (2002) 31-39
35. Weed D.W., Edmundson G.K., Vicini F.A., et al. Accelerated partial breast irradiation: A dosimetric comparison of three different techniques. Brachytherapy 4 (2005) 121-129